IL6 and COVID-19: IL-6 inhibitor, which was used as a treatment for rheumatoid arthritis and CRS associated with CAR-T cell therapies for cancer, has now repurposed to treating COVID-19 in severe and critical patients as recommended by a Chinese government guideline83.